Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 5-iso PGF2a VI cPLA2i 1.0 BCD110605C16 0.907 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 1.0 BCD110605C18 0.499 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 1.0 BCD110605C17 0.435 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 4.0 BCD110605C34 0.521 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 4.0 BCD110605C36 0.715 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 4.0 BCD110605C35 0.615 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 20.0 BCD110605C53 0.545 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 20.0 BCD110605C54 0.659 pmol/ml of medium
- 5-iso PGF2a VI cPLA2i 20.0 BCD110605C52 0.914 pmol/ml of medium
- 5-iso PGF2a VI PLDi 1.0 BCD110605C10 0.527 pmol/ml of medium
- 5-iso PGF2a VI PLDi 1.0 BCD110605C12 0.512 pmol/ml of medium
- 5-iso PGF2a VI PLDi 1.0 BCD110605C11 0.43 pmol/ml of medium
- 5-iso PGF2a VI PLDi 4.0 BCD110605C30 0.594 pmol/ml of medium
- 5-iso PGF2a VI PLDi 4.0 BCD110605C29 0.415 pmol/ml of medium
- 5-iso PGF2a VI PLDi 4.0 BCD110605C28 0.645 pmol/ml of medium
- 5-iso PGF2a VI PLDi 20.0 BCD110605C48 0.807 pmol/ml of medium
- 5-iso PGF2a VI PLDi 20.0 BCD110605C47 0.849 pmol/ml of medium
- 5-iso PGF2a VI PLDi 20.0 BCD110605C46 0.848 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 1.0 BCD110605C19 0.35 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 1.0 BCD110605C21 0.426 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 1.0 BCD110605C20 0.427 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 4.0 BCD110605C39 0.146 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 4.0 BCD110605C37 0.412 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 4.0 BCD110605C38 0.646 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 20.0 BCD110605C55 0.87 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 20.0 BCD110605C57 0.906 pmol/ml of medium
- 5-iso PGF2a VI KDO+cPLA2i 20.0 BCD110605C56 0.678 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 1.0 BCD110605C15 0.552 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 1.0 BCD110605C14 0.554 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 1.0 BCD110605C13 0.564 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 4.0 BCD110605C32 0.824 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 4.0 BCD110605C31 0.944 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 4.0 BCD110605C33 0.762 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 20.0 BCD110605C49 1.6 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 20.0 BCD110605C51 1.14 pmol/ml of medium
- 5-iso PGF2a VI KDO+PLDi 20.0 BCD110605C50 0.854 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 1.0 BCD110605C07 0.613 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 1.0 BCD110605C09 0.39 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 1.0 BCD110605C08 0.46 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 4.0 BCD110605C25 0.856 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 4.0 BCD110605C26 0.651 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 4.0 BCD110605C27 0.806 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 20.0 BCD110605C45 0.954 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 20.0 BCD110605C43 0.855 pmol/ml of medium
- 5-iso PGF2a VI KDO + ATP 20.0 BCD110605C44 1.14 pmol/ml of medium
- 5-iso PGF2a VI C 0.0 BCD110605C02 0.441 pmol/ml of medium
- 5-iso PGF2a VI C 0.0 BCD110605C01 0.494 pmol/ml of medium
- 5-iso PGF2a VI C 0.0 BCD110605C03 0.351 pmol/ml of medium
- 5-iso PGF2a VI C 1.0 BCD110605C06 0.42 pmol/ml of medium
- 5-iso PGF2a VI C 1.0 BCD110605C05 0.407 pmol/ml of medium